Stimuli-responsive hydrogels have been widely researched as carrier systems, due to their excellent biocompatibility and responsiveness to external physiologic environment factors. In this study, dextran-based nanogel with covalently conjugated doxorubicin (DOX) was developed via Schiff base formation using the inverse microemulsion technique. Since the Schiff base linkages are acid-sensitive, drug release profile of the DOX-loaded nanogel would be pH-dependent. In vitro drug release studies confirmed that DOX was released much faster under acidic condition (pH 2.0, 5.0) than that at pH 7.4. Approximately 66, 28, and 9% of drug was released in 72 h at pH 2.0, 5.0, and 7.4, respectively. Cell uptake by the human breast cancer cell (MCF-7) demonstrated that the DOX-loaded dextran nanogel could be internalized through endocytosis and distributed in endocytic compartments inside tumor cells. These results indicated that the Schiff base-containing nanogel can serve as a pH-sensitive drug delivery system. And the presence of multiple aldehyde groups on the nanogel are available for further conjugations of targeting ligands or imaging probes.
LeeESGaoZBaeYH.Recent progress in tumor pH targeting nanotechnology. J Control Release2008;
132: 164–170.
6.
LiuJHuangYKumarAet al.
pH-Sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv2014;
32: 693–710.
7.
PangXJiangYXiaoQet al.
pH-responsive polymer–drug conjugates: design and progress. J Control Release2016;
222: 116–129.
8.
KanamalaMWilsonWRYangMet al.
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials2016;
85: 152–167.
9.
BöhmeIBosserhoffAK.Acidic tumor microenvironment in human melanoma. Pigment Cell Melanoma Res2016;
29: 508–523.
10.
RiehemannKSchneiderSWLugerTAet al.
Nanomedicine – challenge and perspectives. Angew Chem Int Ed2009;
48: 872–897.
11.
ChoiKYLiuGLeeSet al.
Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale2012;
4: 330–342.
12.
DanafarH.Applications of copolymeric nanoparticles in drug delivery systems. Drug Res Stuttg2016;
66: 506–519.
13.
NosratiHRashidiNDanafarHet al.
Anticancer activity of tamoxifen loaded tyrosine decorated biocompatible Fe3O4 magnetic nanoparticles against breast cancer cell lines. J Inorg Organomet Polym2018;
28: 1178–1186.
14.
NosratiHSefidiNSharafiAet al.
Bovine serum albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug. Bioorgan Chem2018;
76: 501–509.
15.
SalehiabarMNosratiHJavaniEet al.
Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int J Biol Macromol2018;
115: 83–89.
16.
HamidiMAzadiARafieiP.Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev2008;
60: 1638–1649.
17.
EckmannDMCompostoRJTsourkasAet al.
Nanogel carrier design for targeted drug delivery. J Mater Chem B2014;
2: 8085–8097.
18.
ChenWMengFChengRet al.
pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release2010;
142: 40–46.
19.
DuJDuXMaoCet al.
Tailor-made dual pH-sensitive polymer–doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc2011;
133: 17560–17563.
20.
SonawaneSJKalhapureRSGovenderT.Hydrazone linkages in pH responsive drug delivery systems. Eur J Pharm Sci2017;
99: 45–65.
21.
ShinJShumPThompsonDH.Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG–lipids. J Control Release2003;
91: 187–200.
22.
SuHJiaQShanS.Synthesis and characterization of Schiff base contained dextran microgels in water-in-oil inverse microemulsion. Carbohydr Polym2016;
152: 156–162.
23.
JalalvandiEHantonLRMorattiSC.Schiff-base based hydrogels as degradable platforms for hydrophobic drug delivery. Eur Polym J2017;
90: 13–24.
24.
ZhaoGLongLZhangLet al.
Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery. Sci Rep2017;
7: 3383
25.
SahuRThakurDSKashyapP.Schiff base: an overview of its medicinal chemistry potential for new drug molecules. Int J Pharm Sci Nanotechnol2012;
5: 1757–1764.
26.
DumitriuS.Polysaccharides in medicinal applications.
Florida:
CRC Press, 1996.
27.
JanesKACalvoPAlonsoMJ.Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev2001;
47: 83–97.
28.
CovielloTMatricardiPMarianecciCet al.
Polysaccharide hydrogels for modified release formulations. J Control Release2007;
119: 5–24.
29.
LiuZJiaoYWangYet al.
Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev2008;
60: 1650–1662.
30.
Caldorera-MooreMPeppasNA.Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv Drug Deliv Rev2009;
61: 1391–1401.
31.
NosratiHSalehiabarMDavaranSet al.
New advances strategies for surface functionalization of iron oxide magnetic nano particles (IONPs). Res Chem Intermed2017;
43: 7423–7442.
32.
HamedNMarziyehSElaheAet al.
Green and one‐pot surface coating of iron oxide magnetic nanoparticles with natural amino acids and biocompatibility investigation. Appl Organometal Chem2018;
32: e4069.
33.
NosratiHSalehiabarMDavaranSet al.
Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells. Drug Develop Ind Pharm2018;
44: 886–894.
34.
NosratiHSalehiabarMManjiliHKet al.
Preparation of magnetic albumin nanoparticles via a simple and one-pot desolvation and co-precipitation method for medical and pharmaceutical applications. Int J Biol Macromol2018;
108: 909–915.
35.
ZhaoHHeindelND.Determination of degree of substitution of formyl groups in polyaldehyde dextran by the hydroxylamine hydrochloride method. Pharm Res1991;
8: 400–402.
36.
MaiaJCarvalhoRACoelhoJFJet al.
Insight on the periodate oxidation of dextran and its structural vicissitudes. Polymer2011;
52: 258–265.
37.
MalapradeL.Oxidation of some polyalcohols by periodic acid: applications. Comptes Rendus1928a;
186: 382–384.
38.
LiYLiuCTanYet al.
In situ hydrogel constructed by starch-based nanoparticles via a Schiff base reaction. Carbohydr Polym2014;
110: 87–94.
39.
AmerHNypelöTSulaevaIet al.
Synthesis and characterization of periodate-oxidized polysaccharides: dialdehyde xylan (DAX). Biomacromolecules2016;
17: 2972–2980.
40.
Sokolsky-PapkovMDombAJGolenserJ.Impact of aldehyde content on amphotericin B−dextran imine conjugate toxicity. Biomacromolecules2006;
7: 1529–1535.
41.
LiDHanJDingJet al.
Acid-sensitive dextran prodrug: a higher molecular weight makes a better efficacy. Carbohydr Polym2017;
161: 33–41.
42.
FengXLiDHanJet al.
Schiff base bond-linked polysaccharide–doxorubicin conjugate for upregulated cancer therapy. Mater Sci Eng C2017;
76: 1121–1128.
43.
BouhadirKHHausmanDSMooneyDJ.Synthesis of cross-linked poly(aldehyde guluronate) hydrogels. Polymer1999;
40: 3575–3584.
44.
MaiaJFerreiraLCarvalhoRet al.
Synthesis and characterization of new injectable and degradable dextran-based hydrogels. Polymer2005;
46: 9604–9614.
45.
PanJF.Preparation and characterization of a novel injectable hydrogel. Adv Genet Eng2013;
2: 105–110.
46.
WuXYuGLuoCet al.
Synthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic acid conjugate with a hydrolyzable Schiff base spacer for treating retinal degeneration. ACS Nano2014;
8: 153–161.
47.
KarukstisKKThompsonEHZWhilesJAet al.
Deciphering the fluorescence signature of daunomycin and doxorubicin. Biophys Chem1998;
73: 249–263.
48.
LinBSuHJinRet al.
Multifunctional dextran micelles as drug delivery carriers and magnetic resonance imaging probes. Sci Bull2015;
60: 1272–1280.
49.
BodleyALiuLFIsraelMet al.
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Res1989;
49: 5969–5978.
50.
ZuninoFCapranicoG.DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anticancer Drug Des1990;
5: 307–317.
51.
CuttsSMNudelmanARephaeliAet al.
The power and potential of doxorubicin-DNA adducts. IUBMB Life2005;
57: 73–81.
52.
BaeYFukushimaSHaradaAet al.
Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem2003;
115: 4788–4791.
53.
DaiJLinSChengDet al.
Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed2011;
50: 9404–9408.
54.
WeiXLuoQSunLet al.
Enzyme- and pH-sensitive branched polymer–doxorubicin conjugate-based nanoscale drug delivery system for cancer therapy. ACS Appl Mater Interfaces2016;
8: 11765–11778.
